Novel diabetes insulin autonomous injection device
By designing storage chambers and slots in the diabetic insulin autonomous injection device, the insulin liquid is stored and injected in batches in the device, solving the chaos caused by carrying multiple reserve containers in the prior art, and improving the convenience of use Sexual and functional comprehensiveness.
Patent Information
- Application Number
- CN202322981805.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-06
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2033-11-06
AI Technical Summary
The existing diabetic insulin autonomous injection device requires multiple insulin storage containers when carrying it for a long time, which can easily lead to portability confusion and inconvenience.
A new type of diabetic insulin self-injection device is designed, including the lower body, upper body, slide rod, sealing ring, storage cavity, sealing gasket and cover plate, allowing insulin liquid to be stored in batches in the device and through the passage of The slot and injection chamber realize the injection of the medicine liquid, supporting the selective replacement of the needle.
The device simplifies the carrying process and supports needle replacement by storing insulin solution in batches in the injection device, improving the convenience of use and comprehensive functions of the injection device.
Smart Images

Figure CN222075647U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of injection devices, in particular to a novel autonomous insulin injection device for diabetes mellitus. Background Art
[0002] Diabetes is a metabolic disease characterized by high blood sugar. High blood sugar is caused by defects in insulin secretion or its biological function, or both. Long-term high blood sugar leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels, and nerves. Patients with more severe diabetes need to use injection devices to inject external insulin liquid into the body in daily life to make up for the lack of insulin in the body.
[0003] Existing self-injection insulin devices for diabetes require that externally stored insulin liquid be drawn into the injection device before the injection of the insulin liquid is completed. Although this method can meet normal usage needs, when carrying the device for a long time, it is necessary to be equipped with multiple insulin storage containers, which results in a large number of insulin to be carried and is prone to confusion. Utility Model Content
[0004] The main purpose of the utility model is to provide a novel diabetic insulin autonomous injection device.
[0005] The purpose of the utility model can be achieved by adopting the following technical solutions:
[0006] A novel autonomous insulin injection device for diabetes comprises a lower body, the lower end of which is slidably connected to a protective tube, the upper end of which is formed with an upper body, a sliding rod is slidably connected inside the upper body, a pressure handle is fixedly installed on the upper end of the sliding rod, a sealing ring is installed on the lower end of the sliding rod through a slot, an injection chamber is provided at the connection between the lower body and the sealing ring, a needle is inserted into the lower part of the injection chamber, storage chambers are provided on the periphery of the injection chamber, there are multiple storage chambers and they are evenly distributed, a sealing gasket is slidably connected inside the storage chamber, a through groove is provided between the injection chamber and the storage chamber, and a cover plate is fixedly connected to the upper end of the sealing gasket.
[0007] Preferably, the lower body has a conical structure, and a sliding cavity is provided at the connection between the upper body and the sliding rod.
[0008] Preferably, the injection chamber matches the size of the sealing ring.
[0009] Preferably, a socket is formed at the connection between the lower body and the needle, and the needle is plugged into the socket.
[0010] Preferably, the through groove is sloped.
[0011] Preferably, the outer side wall of the cover plate is raised, and the outer side wall of the cover plate is subjected to anti-slip frosting treatment.
[0012] Preferably, an anti-slip travel cavity is provided at the connection between the lower fuselage and the protective tube, and the protective tube is in a T-shaped ring structure.
[0013] Beneficial technical effects of the utility model:
[0014] The utility model can be used as an independent insulin injection device for diabetes through the design of a lower body, an upper body, a sliding rod, a sealing ring, a needle, a storage chamber, a sealing pad, a through groove and a cover plate. The device is equipped with a storage chamber for insulin liquid, so that the insulin liquid to be carried out can be stored in batches inside the injection device. When injection is needed, the insulin liquid in the storage chamber only needs to be guided into the injection chamber to perform the injection operation. At the same time, the needle used for the injection can be selectively replaced, so that the use function of the injection device can be more comprehensive. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 It is a structural schematic diagram of a preferred embodiment of a novel diabetes insulin autonomous injection device according to the utility model;
[0016] Figure 2 It is a main cross-sectional view of a preferred embodiment of a novel diabetes insulin autonomous injection device according to the utility model;
[0017] Figure 3 In a preferred embodiment of a novel diabetes insulin autonomous injection device according to the utility model Figure 2 Schematic diagram of the structure of the separation slide bar.
[0018] The following are the descriptions of the reference numerals:
[0019] 1. Lower body; 2. Protective tube; 3. Upper body; 4. Sliding rod; 5. Pressing handle; 6. Sealing ring; 7. Injection chamber; 8. Needle; 9. Pull-out socket; 10. Storage chamber; 11. Sealing pad; 12. Through groove; 13. Cover plate; 14. Anti-slip stroke chamber. DETAILED DESCRIPTION
[0020] In order to make the technical solution of the present invention more clear and specific to those skilled in the art, the present invention is further described in detail below in conjunction with embodiments and drawings, but the implementation methods of the present invention are not limited thereto.
[0021] like Figure 1-Figure 3As shown, a novel diabetes insulin self-injection device provided in this embodiment comprises a lower body 1, a protective tube 2 is slidably connected to the lower end of the lower body 1, an upper body 3 is formed on the upper end of the lower body 1, a slide bar 4 is slidably connected inside the upper body 3, a pressing handle 5 is fixedly installed on the upper end of the slide bar 4, a sealing ring 6 is installed on the lower end of the slide bar 4 through a slot, an injection chamber 7 is provided at the connection between the lower body 1 and the sealing ring 6, a needle 8 is inserted into the lower part of the injection chamber 7 of the lower body 1, and the lower body 1 is provided at the lower end of the injection chamber 7. Storage cavities 10 are provided on the periphery of the injection chamber 7. There are multiple storage cavities 10 and they are evenly distributed. A sealing gasket 11 is slidably connected inside the storage cavity 10. A through groove 12 is provided between the injection chamber 7 and the storage cavity 10. A cover plate 13 is fixedly connected to the upper end of the sealing gasket 11. When the sealing ring 6 moves downward into the injection chamber 7, it will produce a sealing effect inside the injection chamber 7. The sealing gasket 11 can be manually adjusted to control the connection between the storage cavity 10 and the injection chamber 7.
[0022] The lower body 1 is of a conical structure, and a sliding cavity is provided at the connection between the upper body 3 and the slide rod 4 to ensure that the slide adjustment of the slide rod 4 is smooth and stable.
[0023] The size of the injection chamber 7 matches that of the sealing ring 6 , and the sealing ring 6 can produce a sealing effect on the injection chamber 7 , thereby squeezing the insulin liquid in the injection chamber 7 to complete the injection operation.
[0024] A pull-out socket 9 is formed at the connection between the lower body 1 and the needle 8, and the needle 8 is plugged into the pull-out socket 9, so that the needle 8 can be selectively replaced.
[0025] The through groove 12 is in a slope shape, so that the insulin solution stored in the storage cavity 10 can enter the injection chamber 7 through the through groove 12 .
[0026] The outer side wall of the cover plate 13 is raised, and the outer side wall of the cover plate 13 is anti-slip frosted to facilitate the user to move the cover plate 13.
[0027] An anti-drop stroke cavity 14 is provided at the connection between the lower body 1 and the protective tube 2. The protective tube 2 is a T-shaped ring structure. The protective tube 2 can provide a protective effect for the needle 8 during use to prevent the needle 8 from accidentally breaking. During injection, the protective tube 2 can slide and shrink into the lower body 1 after being compressed, so that the needle 8 protrudes to facilitate the completion of the injection operation.
[0028] The working principle of the device is as follows: before going out, the user can push the cover 13 upwards so that it can slide out from the lower body 1, and then the insulin solution to be stored can be injected into the storage chamber 10, and the cover 13 can be reset so that the sealing gasket 11 can seal the storage chamber 10. When injection is needed, the user can choose to push one of the cover plates 13 upwards so that the sealing gasket 11 can slide upwards, and after the storage chamber 10 is connected with the through groove 12, the sealing gasket 11 can be controlled to stop moving. Then the user can flip the lower body 1 over so that the insulin solution stored in the storage chamber 10 can enter the injection chamber 7 through the through groove 12, and then the user can use the needle 8 to pierce the body part, and press the pressure handle 5 to move the slide rod 4 and the sealing ring 6 downward, and the sealing gasket 6 can squeeze the insulin solution in the injection chamber 7 so that it enters the human body through the needle 8 to complete the injection. After the injection is completed, the user can choose whether to remove the needle 8 and replace it according to actual needs.
[0029] The above are only further embodiments of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes within the scope disclosed by the present invention according to the technical solution and concept of the present invention, which fall within the protection scope of the present invention.
Claims
1. A novel diabetes insulin autonomous injection device, characterized in that: The invention comprises a lower body (1), the lower end of which is slidably connected to a protective tube (2), the upper end of which is formed with an upper body (3), a sliding rod (4) is slidably connected inside the upper body (3), a pressing handle (5) is fixedly mounted on the upper end of the sliding rod (4), a sealing ring (6) is mounted on the lower end of the sliding rod (4) via a slot, an injection chamber (7) is provided at the connection between the lower body (1) and the sealing ring (6), a needle (8) is inserted into the lower body (1) below the injection chamber (7), the lower body (1) is provided with storage chambers (10) at the periphery of the injection chamber (7), the storage chambers (10) are multiple and evenly distributed, a sealing gasket (11) is slidably connected inside the storage chamber (10), a through groove (12) is provided between the injection chamber (7) and the storage chamber (10), and a cover plate (13) is fixedly mounted on the upper end of the sealing gasket (11).
2. A novel diabetes insulin autonomous injection device according to claim 1, characterized in that: The lower body (1) is of a conical structure, and a sliding cavity is provided at the connection between the upper body (3) and the sliding rod (4).
3. A novel diabetes insulin autonomous injection device according to claim 2, characterized in that: The injection chamber (7) matches the size of the sealing ring (6).
4. A novel diabetes insulin autonomous injection device according to claim 3, characterized in that: A plug socket (9) is formed at the connection between the lower body (1) and the needle head (8), and the needle head (8) is plugged into the plug socket (9).
5. A novel diabetes insulin autonomous injection device according to claim 4, characterized in that: The through groove (12) is in a slope shape.
6. A novel diabetes insulin autonomous injection device according to claim 5, characterized in that: The outer side wall of the cover plate (13) is raised, and the outer side wall of the cover plate (13) is subjected to anti-slip frosting treatment.
7. A novel diabetes insulin autonomous injection device according to claim 6, characterized in that: An anti-drop stroke cavity (14) is provided at the connection between the lower fuselage (1) and the protective tube (2), and the protective tube (2) is in a T-shaped ring structure.
